Melita Irving, Group Leader,
University of lausanne

Dr. Melita Irving is a Group Leader at the Ludwig Institute for Cancer Research at the University of Lausanne, where she leads a research program focused on T-cell engineering for cancer immunotherapy. Her work aims to optimize both viral and non-viral gene engineering methods and develop...